Effect of N-DicyclopropylmethyI-amino-2-oxazoline (S-3341) on Antioxidant Status and Nitric Oxide in Hypertensive Patients

References

• Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am. J. Cardiol. 1996; 77: 31C–37C1. Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am. J. Cardiol. 1996; 77: 31C–37C
   PubMedGoogle Scholar
• Brown M. J. Sites of action of a, agonists and antagonists. Am. J. Cardiol. 1988; 61: 18D–21D2. Brown M. J. Sites of action of a, agonists and antagonists. Am. J. Cardiol. 1988; 61: 18D–21D
   PubMed Web of Science ®Google Scholar
• Cosentino F., Sill C. J., Katusic Z. S. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 1994; 23: 229, 2353. Cosentino F., Sill C. J., Katusic Z. S. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 1994; 23: 229, 235
   PubMed Web of Science ®Google Scholar
• Davies M. G., Fulton G. J., Hagen P. O. Clinical biology of nitric oxide. Br. J. Surgery 1995; 82: 1598, 16104. Davies M. G., Fulton G. J., Hagen P. O. Clinical biology of nitric oxide. Br. J. Surgery 1995; 82: 1598, 1610
   PubMed Web of Science ®Google Scholar
• Dollery C. T. Advantages and disadvantages of α2-adrenoceptor agonists for systemic hypertension. Am. J. Cardiol. 1988; 61: 1D–5D5. Dollery C. T. Advantages and disadvantages of α2-adrenoceptor agonists for systemic hypertension. Am. J. Cardiol. 1988; 61: 1D–5D
   PubMed Web of Science ®Google Scholar
• Giugliano D., Ceriello A., Paolisso G. Diabetes mellitus, hypertension and cardiovascular disease: which role for oxidative stress?. Metabolism 1995; 44: 363, 3686. Giugliano D., Ceriello A., Paolisso G. Diabetes mellitus, hypertension and cardiovascular disease: which role for oxidative stress?. Metabolism 1995; 44: 363, 368
   PubMed Web of Science ®Google Scholar
• Goodman and Gilman's The Pharmacological Basis of Therapeutics 9th edn, G. A. Goodman, J. G. Hardrnan, C. E. Limbird. McGraw-Hill, USA 1996; 242, Eds7. Goodman and Gilman's The Pharmacological Basis of Therapeutics 9th edn, G. A. Goodman, J. G. Hardrnan, C. E. Limbird. McGraw-Hill, USA 1996; 242, Eds
   Google Scholar
• Goth J. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 1991; 196: 143, 1528. Goth J. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 1991; 196: 143, 152
   PubMed Web of Science ®Google Scholar
• Green L. C., Wagner D. A., Glagowski J., Skipper P. L, Wishnok S. S., Tannenbaum S. R. Analysis of nitrite and nitrate in biological fluids. Anal. Biochem. 1982; 126: 131, 1389. Green L. C., Wagner D. A., Glagowski J., Skipper P. L, Wishnok S. S., Tannenbaum S. R. Analysis of nitrite and nitrate in biological fluids. Anal. Biochem. 1982; 126: 131, 138
   PubMed Web of Science ®Google Scholar
• Hashim S. A., Schuttringer G. R. Rapid determination of tocopherol in macro- and microquantities of plasma. Am. J. Clin. Nutr. 1966; 19: 137, 14510. Hashim S. A., Schuttringer G. R. Rapid determination of tocopherol in macro- and microquantities of plasma. Am. J. Clin. Nutr. 1966; 19: 137, 145
   PubMed Web of Science ®Google Scholar
• Jain S. K., Wise R. Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia. Mol. Cell Biochem. 1995; 151: 33, 3811. Jain S. K., Wise R. Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia. Mol. Cell Biochem. 1995; 151: 33, 38
   PubMed Web of Science ®Google Scholar
• Itono Y., Fridovvich I. Superoxide radical inhibits catalase. J. Biol. Chem. 1982; 157: 1, 812. Itono Y., Fridovvich I. Superoxide radical inhibits catalase. J. Biol. Chem. 1982; 157: 1, 8
   Google Scholar
• Kumar K. V., Das U. N. Are free radicals involved in the pathobiology of human essential hypertension?. Free Radical Res. Commun. 1993; 19: 59, 6613. Kumar K. V., Das U. N. Are free radicals involved in the pathobiology of human essential hypertension?. Free Radical Res. Commun. 1993; 19: 59, 66
   PubMed Web of Science ®Google Scholar
• Lockette W., Otsuka Y., Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8: 61–66, Suppl 214. Lockette W., Otsuka Y., Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8: 61–66, Suppl 2
   Web of Science ®Google Scholar
• Liischer T. F., Dahi Y., Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J. Cardiovasc. Pharmacol. 1992; 19: S34–S42, Suppl 515. Liischer T. F., Dahi Y., Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J. Cardiovasc. Pharmacol. 1992; 19: S34–S42, Suppl 5
   PubMed Web of Science ®Google Scholar
• Luscher T. F., Wenzel R. R., Moreau P., Takase H. Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases. Cardiovasc. Drug Ther. 1995; 9: 509–523, Suppl 316. Luscher T. F., Wenzel R. R., Moreau P., Takase H. Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases. Cardiovasc. Drug Ther. 1995; 9: 509–523, Suppl 3
   PubMed Web of Science ®Google Scholar
• Luscher T. F., Vanhoutte P. M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8: 344, 34817. Luscher T. F., Vanhoutte P. M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8: 344, 348
   PubMed Web of Science ®Google Scholar
• Martinek R. G. Method for the determination of vitamin E (total tocopherols) in serum. Clin. Chem. 1964; 10: 1078, 108718. Martinek R. G. Method for the determination of vitamin E (total tocopherols) in serum. Clin. Chem. 1964; 10: 1078, 1087
   PubMed Web of Science ®Google Scholar
• Moshage H., Kok B., Huizenga J. R., Jansen P. L. M. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 1995; 41: 892, 89619. Moshage H., Kok B., Huizenga J. R., Jansen P. L. M. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 1995; 41: 892, 896
   PubMed Web of Science ®Google Scholar
• Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M. Does superoxide underlie in the patho-genesis of hypertension?. Proc. Natl. Acad. Sci. USA 1991; 88: 10045, 1004820. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M. Does superoxide underlie in the patho-genesis of hypertension?. Proc. Natl. Acad. Sci. USA 1991; 88: 10045, 10048
   PubMed Web of Science ®Google Scholar
• Okhawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by tba reaction. Anal. Biochem. 1979; 95: 351, 35821. Okhawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by tba reaction. Anal. Biochem. 1979; 95: 351, 358
   PubMed Web of Science ®Google Scholar
• Sannajust F., Head G. A. Involvement of imidazoline-preferring receptor in regulation of sympathetic tone. Am. J. Cardiol. 1994; 74: 7A–20A22. Sannajust F., Head G. A. Involvement of imidazoline-preferring receptor in regulation of sympathetic tone. Am. J. Cardiol. 1994; 74: 7A–20A
   PubMed Web of Science ®Google Scholar
• Packer L. Protective role of vitamin E in biological systems. Am. J. Clin. Nutr. 1991; 53: 1050s–1055s23. Packer L. Protective role of vitamin E in biological systems. Am. J. Clin. Nutr. 1991; 53: 1050s–1055s
   PubMed Web of Science ®Google Scholar
• Panza J. A., Arshed A. Q., Brush J. E., Epstein S. E. Abnormal endo-thelium-dependent vascular relaxation in patients with essential hypertension. N. Eng. J. Med. 1990; 323: 22, 2724. Panza J. A., Arshed A. Q., Brush J. E., Epstein S. E. Abnormal endo-thelium-dependent vascular relaxation in patients with essential hypertension. N. Eng. J. Med. 1990; 323: 22, 27
   PubMed Web of Science ®Google Scholar
• Rump A. F. E., Rosen R., Klaus W. Cardioprotection by superoxide dismutase: a catecholamine-dependent process?. Anest. Analg. 1993; 76: 239, 24625. Rump A. F. E., Rosen R., Klaus W. Cardioprotection by superoxide dismutase: a catecholamine-dependent process?. Anest. Analg. 1993; 76: 239, 246
   PubMed Web of Science ®Google Scholar
• Takase H., Moreau P., Kung C. F., Nava E., Luscher T. F. Anti-hypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 1996; 27: 25, 3126. Takase H., Moreau P., Kung C. F., Nava E., Luscher T. F. Anti-hypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 1996; 27: 25, 31
   PubMed Web of Science ®Google Scholar
• Tse W. Y., Maxwell S. R. J., Thomason H., Blann A., Thorpe G. H. G., Waite M., Holder R. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J. Human Hypertension 1994; 8: 843, 84927. Tse W. Y., Maxwell S. R. J., Thomason H., Blann A., Thorpe G. H. G., Waite M., Holder R. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J. Human Hypertension 1994; 8: 843, 849
   PubMed Web of Science ®Google Scholar
• Wenmalm A. Review: endothelial nitric oxide and cardiovascular disease. J. Intern. Med. 1994; 235: 317, 32728. Wenmalm A. Review: endothelial nitric oxide and cardiovascular disease. J. Intern. Med. 1994; 235: 317, 327
   Web of Science ®Google Scholar
• Vane J. R., Anggard E. E., Botting R. M. Regulatory functions of the vascular endothelium. Mechanism of disease. N. Engl. J. Med. 1990; 323: 27, 3629. Vane J. R., Anggard E. E., Botting R. M. Regulatory functions of the vascular endothelium. Mechanism of disease. N. Engl. J. Med. 1990; 323: 27, 36
   PubMed Web of Science ®Google Scholar
• Vanhoutte P. M., Boulanger C. M., Mombouli J. V. Endothelium-derived relaxing factors and converting enzyme inhibition. Am. J. Cardiol. 1995; 76: 3E–12E30. Vanhoutte P. M., Boulanger C. M., Mombouli J. V. Endothelium-derived relaxing factors and converting enzyme inhibition. Am. J. Cardiol. 1995; 76: 3E–12E
   PubMed Web of Science ®Google Scholar
• van Zwieten P. A. Pharmacology of the α2-receptor agonist N-dicyclo-propylmethyl-amino-2-oxazoline. Am. J. Cardiol. 1988; 61: 6D–14D31. van Zwieten P. A. Pharmacology of the α2-receptor agonist N-dicyclo-propylmethyl-amino-2-oxazoline. Am. J. Cardiol. 1988; 61: 6D–14D
   PubMedGoogle Scholar